View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AA66 Publication ID: Spring 2003 
Title: Chemical Mixtures Containing Listed Forms of Phosphorus 
Abstract: In a previous rulemaking, (RIN 1117-AA57) DEA made red phosphorus, white phosphorus, and hypophosphorous acid (and its salts) List I chemicals. Although 1117-AA57 was effective as of November 16, 2001, (and it remains in effect) DEA asked for and received comments at the final rule stage on an exemption. DEA is still considering these comments and will publish a second final rule under the RIN 1117-AA57 finalizing that rulemaking. By this rulemaking (1117-AA66) DEA is requesting information from interested parties to propose regulations governing chemical mixtures containing the List I chemicals red phosphorus, white phosphorus, and hypophosphorous acid (and its salts). Currently, all chemical mixtures containing red phosphorus, white phosphorus, and hypophosphorous acid (and its salts) are exempt from regulation. These mixtures will remain exempt until publication of rulemakings regarding chemical mixtures (see RIN 1117-AA31). These three List I chemicals are used industrially and have multiple commercial purposes. They are also used in the illicit production of methamphetamine and amphetamine. Information sought will help determine whether there are chemical mixtures containing red phosphorus, white phosphorus, and hypophosphorous acid (and its salts) which should be exempt from the regulations governing listed chemicals. 
Agency: Department of Justice(DOJ)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 1310   
Legal Authority: 21 USC 802    21 USC 830    21 USC 871(b)   
Legal Deadline:  None
Timetable:
Action Date FR Cite
ANPRM  01/31/2003  68 FR 4968   
ANPRM Comment Period End  04/01/2003    
NPRM  09/00/2003    
NPRM Comment Period End  11/00/2003    
Additional Information: DEA-228
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
Related RINs: Related to 1117-AA31, Related to 1117-AA57 
Agency Contact:
Frank Sapienza
Chief, Drug and Chemical Evaluation Section
Department of Justice
Drug Enforcement Administration
Office of Diversion Control,
Washington, DC 20537
Phone:202 307-7183